Orient Bio (002630.KS) Stock Price

Orient Bio Price

CLOSED
873.00KRW+23.00 (+2.67 %)
Market closed

Over the last 19 years Orient Bio grew revenue by 2.0% annually, reaching 29.40 B KRW. Earnings per share have grown at 11.5% per year over the last 17 years. For Orient Bio, the net margin of -44.9% is up versus -62.1% a few years ago. The stock trades about 11% above its 52-week low.

Orient Bio stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Orient Bio over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Orient Bio stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Orient Bio's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Orient Bio Stock Price History
DateOrient Bio Price
7/15/2026873.00 KRW
7/14/2026850.00 KRW
7/13/2026843.00 KRW
7/10/2026882.00 KRW
7/9/2026859.00 KRW
7/8/2026906.00 KRW
7/7/2026917.00 KRW
7/6/2026916.00 KRW
7/3/2026890.00 KRW
7/2/2026875.00 KRW
7/1/2026886.00 KRW
6/30/2026885.00 KRW
6/29/2026899.00 KRW
6/26/2026834.00 KRW
6/25/2026821.00 KRW
6/24/2026880.00 KRW
6/23/2026793.00 KRW
6/22/2026881.00 KRW
6/19/2026864.00 KRW
6/18/2026902.00 KRW
6/17/2026940.00 KRW
6/16/2026951.00 KRW
6/15/2026996.00 KRW
6/12/2026984.00 KRW
6/11/2026978.00 KRW
6/10/2026857.00 KRW
6/9/2026783.00 KRW
6/8/2026966.00 KRW
6/5/2026966.00 KRW
6/4/2026966.00 KRW
6/2/2026966.00 KRW
6/1/2026966.00 KRW
5/29/2026966.00 KRW
5/28/2026966.00 KRW
5/27/2026966.00 KRW
5/26/2026966.00 KRW
5/22/2026966.00 KRW
5/21/2026966.00 KRW
5/20/2026966.00 KRW
5/19/2026966.00 KRW
5/18/2026966.00 KRW
5/15/2026956.00 KRW
5/14/2026986.00 KRW
5/13/2026968.00 KRW
5/12/2026934.00 KRW
5/11/2026952.00 KRW
5/8/20261,000.00 KRW
5/7/20261,016.00 KRW
5/6/20261,036.00 KRW
5/4/20261,062.00 KRW
4/30/20261,074.00 KRW
4/29/20261,088.00 KRW
4/28/20261,102.00 KRW
4/27/20261,112.00 KRW
4/24/20261,114.00 KRW
4/23/20261,110.00 KRW
4/22/20261,130.00 KRW
4/21/20261,130.00 KRW
4/20/20261,164.00 KRW
4/17/20261,176.00 KRW
4/16/20261,158.00 KRW
4/15/20261,140.00 KRW
4/14/20261,094.00 KRW
4/13/20261,094.00 KRW
4/10/20261,104.00 KRW
4/9/20261,094.00 KRW
4/8/20261,120.00 KRW
4/7/20261,108.00 KRW
4/6/20261,102.00 KRW
4/3/20261,138.00 KRW
4/2/20261,140.00 KRW
4/1/20261,202.00 KRW
3/31/20261,156.00 KRW
3/30/20261,202.00 KRW
3/27/20261,256.00 KRW
3/26/20261,164.00 KRW
3/25/20261,230.00 KRW
3/24/20261,050.00 KRW
3/23/20261,048.00 KRW
3/20/20261,100.00 KRW
3/19/20261,058.00 KRW
3/18/20261,088.00 KRW
3/17/20261,078.00 KRW
3/16/20261,058.00 KRW
3/13/20261,076.00 KRW
3/12/20261,094.00 KRW
3/11/20261,114.00 KRW
3/10/20261,114.00 KRW
3/9/20261,092.00 KRW
3/6/20261,162.00 KRW
3/5/20261,164.00 KRW
3/4/20261,048.00 KRW
3/3/20261,180.00 KRW
2/27/20261,216.00 KRW
2/26/20261,248.00 KRW
2/25/20261,328.00 KRW
2/24/20261,360.00 KRW
2/23/20261,348.00 KRW
2/20/20261,230.00 KRW
2/19/20261,214.00 KRW
2/13/20261,222.00 KRW
2/12/20261,410.00 KRW
2/11/20261,086.00 KRW
2/10/20261,096.00 KRW
2/9/20261,086.00 KRW
2/6/20261,076.00 KRW
2/5/20261,076.00 KRW
2/4/20261,100.00 KRW
2/3/20261,078.00 KRW
2/2/20261,074.00 KRW
1/30/20261,112.00 KRW
1/29/20261,164.00 KRW
1/28/20261,142.00 KRW
1/27/20261,132.00 KRW
1/26/20261,124.00 KRW
1/23/20261,090.00 KRW
1/22/20261,058.00 KRW
1/21/20261,070.00 KRW
1/20/20261,124.00 KRW
1/19/20261,104.00 KRW
1/16/20261,114.00 KRW
1/15/20261,136.00 KRW
1/14/20261,146.00 KRW
1/13/20261,158.00 KRW
1/12/20261,176.00 KRW
1/9/20261,190.00 KRW
1/8/20261,194.00 KRW
1/7/20261,210.00 KRW
1/6/20261,230.00 KRW
1/5/20261,256.00 KRW
1/2/20261,232.00 KRW
12/30/20251,202.00 KRW
12/29/20251,210.00 KRW
12/26/20251,166.00 KRW
12/24/20251,170.00 KRW
12/23/20251,176.00 KRW
12/22/20251,228.00 KRW
12/19/20251,202.00 KRW
12/18/20251,204.00 KRW
12/17/20251,240.00 KRW
12/16/20251,222.00 KRW
12/15/20251,240.00 KRW
12/12/20251,270.00 KRW
12/11/20251,288.00 KRW
12/10/20251,246.00 KRW
12/9/20251,284.00 KRW
12/8/20251,288.00 KRW
12/5/20251,326.00 KRW
12/4/20251,332.00 KRW
12/3/20251,254.00 KRW
12/2/20251,264.00 KRW
12/1/20251,260.00 KRW
11/28/20251,202.00 KRW
11/27/20251,134.00 KRW
11/26/20251,124.00 KRW
11/25/20251,090.00 KRW
11/24/20251,110.00 KRW
11/21/20251,142.00 KRW
11/20/20251,208.00 KRW
11/19/20251,158.00 KRW
11/18/20251,208.00 KRW
11/17/20251,260.00 KRW
11/14/20251,308.00 KRW
11/13/20251,326.00 KRW
11/12/20251,198.00 KRW
11/11/20251,106.00 KRW
11/10/20251,166.00 KRW
11/7/20251,168.00 KRW
11/6/20251,196.00 KRW
11/5/20251,092.00 KRW
11/4/20251,076.00 KRW
11/3/20251,050.00 KRW
10/31/20251,098.00 KRW
10/30/20251,108.00 KRW
10/29/20251,130.00 KRW
10/28/20251,162.00 KRW
10/27/20251,160.00 KRW
10/24/20251,132.00 KRW
10/23/20251,160.00 KRW
10/22/20251,194.00 KRW
10/21/20251,184.00 KRW
10/20/20251,170.00 KRW
10/17/20251,104.00 KRW
10/16/20251,148.00 KRW
10/15/20251,148.00 KRW
10/14/20251,132.00 KRW
10/13/20251,128.00 KRW
10/10/20251,118.00 KRW
10/2/20251,158.00 KRW
10/1/20251,144.00 KRW
9/30/20251,152.00 KRW
9/29/20251,168.00 KRW
9/26/20251,144.00 KRW
9/25/20251,166.00 KRW
9/24/20251,174.00 KRW
9/23/20251,174.00 KRW
9/22/20251,184.00 KRW
9/18/20251,222.00 KRW
9/17/20251,200.00 KRW
9/16/20251,202.00 KRW
9/15/20251,216.00 KRW
9/12/20251,248.00 KRW
9/11/20251,260.00 KRW
9/10/20251,284.00 KRW
9/9/20251,300.00 KRW
9/8/20251,246.00 KRW
9/5/20251,214.00 KRW
9/4/20251,200.00 KRW
9/3/20251,194.00 KRW
9/2/20251,150.00 KRW
9/1/20251,174.00 KRW
8/29/20251,182.00 KRW
8/28/20251,228.00 KRW
8/27/20251,212.00 KRW
8/26/20251,238.00 KRW
8/25/20251,266.00 KRW
8/22/20251,284.00 KRW
8/21/20251,268.00 KRW
8/20/20251,250.00 KRW
8/19/20251,274.00 KRW
8/18/20251,264.00 KRW
8/14/20251,318.00 KRW
8/13/20251,302.00 KRW
8/12/20251,294.00 KRW
8/11/20251,306.00 KRW
8/8/20251,332.00 KRW
8/7/20251,358.00 KRW
8/6/20251,348.00 KRW
8/5/20251,368.00 KRW
8/4/20251,340.00 KRW
8/1/20251,304.00 KRW
7/31/20251,370.00 KRW
7/30/20251,340.00 KRW
7/29/20251,364.00 KRW
7/28/20251,366.00 KRW
7/25/20251,362.00 KRW
7/24/20251,400.00 KRW
7/23/20251,398.00 KRW
7/22/20251,446.00 KRW
7/21/20251,466.00 KRW
7/18/20251,462.00 KRW
7/17/20251,470.00 KRW
7/16/20251,444.00 KRW
Access this data via the Eulerpool API
Get Free API Key

Orient Bio Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
121.21 B KRW
-6.56 B KRW
-13.87 B KRW
Jan 1, 2019
30.37 B KRW
-10.12 B KRW
-19.51 B KRW
Jan 1, 2020
37.70 B KRW
-11.25 B KRW
-10.88 B KRW
Jan 1, 2021
25.18 B KRW
-5.19 B KRW
-15.63 B KRW
Jan 1, 2022
26.28 B KRW
-3.78 B KRW
34.20 B KRW
Jan 1, 2023
28.82 B KRW
1.45 B KRW
-12.42 B KRW
Jan 1, 2024
28.01 B KRW
-645.95 M KRW
12.87 B KRW
Jan 1, 2025
29.40 B KRW
-3.08 B KRW
-13.19 B KRW

Orient Bio Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 16, 2026, 1:19 AM
 
REVENUEB KRW
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB KRW
NET INCOMEB KRW
NET INCOME GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
40.4647.5752.0576.9883.7293.71105.05109.02121.2130.3737.7025.1826.2828.8228.0129.40
-5.4917.589.4447.898.7611.9312.103.7811.18-74.9424.12-33.214.369.68-2.824.97
28.1824.8128.0923.0615.8117.6615.317.6812.319.9119.1024.6134.3034.0934.2224.48
11.4011.8014.6217.7513.2416.5516.098.3714.933.017.206.209.019.829.587.20
-0.582.64-10.600.68-9.55-1.75-3.01-19.58-13.87-19.51-10.88-15.6334.20-12.4212.87-13.19
-6.90-554.66-502.05-106.38-1,512.87-81.6972.04550.78-29.2040.69-44.2243.67-318.76-136.33-203.61-202.51
43.0043.0043.0043.0048.0052.0066.0073.0076.0078.00102.00113.23118.58118.57118.57118.57
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Orient Bio generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Orient Bio retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Orient Bio's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Orient Bio has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Orient Bio's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Orient Bio stock margins

The Orient Bio margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Orient Bio. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Orient Bio.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
12.31 %
-5.41 %
-11.44 %
Jan 1, 2019
9.91 %
-33.33 %
-64.22 %
Jan 1, 2020
19.10 %
-29.84 %
-28.86 %
Jan 1, 2021
24.61 %
-20.63 %
-62.09 %
Jan 1, 2022
34.30 %
-14.39 %
130.15 %
Jan 1, 2023
34.09 %
5.04 %
-43.11 %
Jan 1, 2024
34.22 %
-2.31 %
45.96 %
Jan 1, 2025
24.48 %
-10.46 %
-44.88 %

Orient Bio Stock Revenue, EBIT, Earnings per Share

The Orient Bio earnings per share therefore indicates how much revenue Orient Bio has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
1,594.84 KRW
-86.36 KRW
-182.43 KRW
Jan 1, 2019
389.40 KRW
-129.79 KRW
-250.08 KRW
Jan 1, 2020
369.60 KRW
-110.28 KRW
-106.68 KRW
Jan 1, 2021
222.38 KRW
-45.88 KRW
-138.07 KRW
Jan 1, 2022
221.59 KRW
-31.88 KRW
288.39 KRW
Jan 1, 2023
243.06 KRW
12.25 KRW
-104.78 KRW
Jan 1, 2024
236.19 KRW
-5.45 KRW
108.55 KRW
Jan 1, 2025
247.94 KRW
-25.95 KRW
-111.29 KRW

Orient Bio business model & stock analysis

Orient Bio Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Orient Bio historical P/E ratio, EBIT multiple, and P/S ratio

Orient Bio annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Orient Bio shares outstanding

The number of shares of Orient Bio was 118.57 M in 2025. This indicates how many shares Orient Bio is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
76.00 M Stocks
Jan 1, 2019
78.00 M Stocks
Jan 1, 2020
102.00 M Stocks
Jan 1, 2021
113.23 M Stocks
Jan 1, 2022
118.58 M Stocks
Jan 1, 2023
118.57 M Stocks
Jan 1, 2024
118.57 M Stocks
Jan 1, 2025
118.57 M Stocks

Orient Bio stock splits

In Orient Bio's history, there have been no stock splits.

Orient Bio Dividend History

8 years of dividend payments

YearAnnual DividendYoY ChangePayments
2000250.00KRW 0.0%1×
1998250.00KRW↓ 50.0%1×
1995500.00KRW↓ 37.5%1×
1994800.00KRW 0.0%1×
1993800.00KRW 0.0%1×
1992800.00KRW 0.0%1×
1991800.00KRW 0.0%1×
1990800.00KRW—1×
Price targets and forecasts for Orient Bio are not yet available.

Orient Bio shareholder structure

% Name
24.00590%
Orient Co., Ltd.
Orient Co., Ltd.
8.08570%
Orient Precision Industries Inc
Orient Precision Industries Inc
2.77430%
Choi (Suk Jong)
Choi (Suk Jong)
0.75549%
Jang (Jae Jin)
Jang (Jae Jin)
0.00312%
Hanwha Asset Management Co., Ltd.
Hanwha Asset Management Co., Ltd.
0.00000%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.

Orient Bio Executives and Management Board

JJ

Jae Jin Jang

(54)

Chairman of the Board, Chief Executive Officer

SC

Ms. Suk Jong Choi

(59)

Vice Chairman of the Board · since 2006

YS

Yeong Cheol Shin

(63)

Vice President · since 2008

JK

Ju Min Kim

(49)

Vice President · since 2008

SK

Sang Nyeon Kim

(52)

Vice President

Frequently asked questions about Orient Bio

5 analysts currently rate the Orient Bio stock: 4 recommend buying, 1 holding and 0 selling.

Orient Bio Analyst Price Targets 2026

All fundamentals and in-depth analysis of Orient Bio

Our stock analysis for Orient Bio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orient Bio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Orient Bio Stock
Orient Bio Revenue→
Orient Bio Stock
Orient Bio Net Income→
Orient Bio Stock
Orient Bio P/E→
Orient Bio Stock
Orient Bio P/S→
Orient Bio Stock
Orient Bio EBIT→
Orient Bio Stock
Orient Bio Dividend→
Orient Bio Stock
Orient Bio Directors Dealings→
Orient Bio Stock
Orient Bio Stocks→
Orient Bio Stock
Orient Bio Market capitalization→
Orient Bio Stock
Orient Bio Debt→
Orient Bio Stock
Orient Bio Liabilities→
Orient Bio Stock
Orient Bio Equity→
Orient Bio Stock
Orient Bio AAQS→
Orient Bio Stock
Orient Bio Employees→
Orient Bio Stock
Orient Bio ROE→
Orient Bio Stock
Orient Bio ROA→
Orient Bio Stock
Orient Bio ROCE→
Orient Bio Stock
Orient Bio News→
Orient Bio Stock
Orient Bio Analyst Price Targets→

Health Stocks

Orient Europharma CoOric PharmaceuticalsOrient Pharma CoOrgenesisOriola OyjOrganon &Orion OyjOrganogenesis HoldingsOrthocellOrganiGram HoldingsOrthofix MedicalOrganigram GlobalAll Stocks A–Z →